Enhanced In Vitro and In Vivo Autophagy Suppression via LC3 siRNA-Loaded “Smart” Nanoparticles and Doxorubicin Combination Therapy in Triple Negative Breast Cancer
- 8 March 2025
- journal article
- Published by American Chemical Society (ACS) in ACS Applied Bio Materials
- Vol. 8 (4) , 2938-2953
Abstract
Autophagy plays a complex role in cancer progression, serving as both a tumor suppressor and a promoter, depending on the context. In triple-negative breast cancer (TNBC), a particularly aggressive subtype with limited therapeutic options, autophagy inhibition has emerged as a promising strategy to enhance the efficacy of chemotherapy. This study investigates the synergistic effects of autophagy suppression using LC3 siRNA-loaded "smart" nanoparticles (LC3siRNA-NPs) in combination with doxorubicin (DOX) to overcome chemoresistance in TNBC. We engineered a well-defined copolymer, poly[hexyl methacrylate-co-2-(dimethylamino) ethyl methacrylate-co-trimethylaminoethyl methacrylate iodide], and a PEG heteroarm beta-cyclodextrin (βCD) core star copolymer that delivers LC3 siRNA, effectively silencing the autophagy-related gene LC3. In vitro, the coadministration of LC3siRNA-NPs and DOX significantly inhibited TNBC cell proliferation, migration, and colony formation, while inducing apoptosis more effectively than either treatment alone. Mechanistically, this combination downregulated key oncogenic markers such as PARP, cyclin D1, and Src, enhancing the therapeutic outcome. In vivo, treatment with LC3siRNA-NPs and DOX in a TNBC xenograft model resulted in superior tumor growth suppression compared to that with monotherapy alone. Our findings highlight the potential of autophagy-targeting nanocarriers to improve chemotherapy outcomes and provide an effective approach to TNBC treatment by enhancing chemotherapeutic sensitivity and reducing tumor resistance.Keywords
Funding Information
- T??rkiye Bilimsel ve Teknolojik Arastirma Kurumu (118Z952)
- T??rkiye Saglik Enstit??eri Baskanligi (3802)
- T??rkiye Burslar?? (YTB)
- Bilimsel Arastirma Projeleri, Erciyes ??niversitesi (FYL-2022-11565)
This publication has 67 references indexed in Scilit:
- Determination of Optimum Ratio of Cationic Polymers and Small Interfering RNA with Agarose Gel Retardation Assay2022
- Expression of LC3B and FIP200/Atg17 in brain metastases of breast cancerJournal of Neuro-Oncology, 2018
- Targeting LC3 and Beclin-1 autophagy genes suppresses proliferation, survival, migration and invasion by inhibition of Cyclin-D1 and uPAR/Integrin β1/ Src signaling in triple negative breast cancer cellsJournal of Cancer Research and Clinical Oncology, 2017
- FOXM1 transcriptionally regulates expression of integrin β1 in triple-negative breast cancerBreast Cancer Research and Treatment, 2017
- PI3K/Akt/mTOR activation by suppression of ELK3 mediates chemosensitivity of MDA-MB-231 cells to doxorubicin by inhibiting autophagyBiochemical and Biophysical Research Communications, 2016
- Development of Degradable, pH‐Sensitive Star Vectors for Enhancing the Cytoplasmic Delivery of Nucleic AcidsAdvanced Functional Materials, 2013
- High expression of LC3B is associated with progression and poor outcome in triple-negative breast cancerMedical Oncology, 2013
- Degradable, pH-sensitive, membrane-destabilizing, comb-like polymers for intracellular delivery of nucleic acidsBiomaterials, 2010
- Induction of autophagy by proteasome inhibitor is associated with proliferative arrest in colon cancer cellsBiochemical and Biophysical Research Communications, 2008
- LC3 conjugation system in mammalian autophagyThe International Journal of Biochemistry & Cell Biology, 2004